Corundum Trust Company, Inc Viatris Inc Transaction History
Corundum Trust Company, Inc
- $46.1 Billion
- Q3 2025
A detailed history of Corundum Trust Company, Inc transactions in Viatris Inc stock. As of the latest transaction made, Corundum Trust Company, Inc holds 24 shares of VTRS stock, worth $257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$257% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,135Shares Held
966MCall Options Held
7.74MPut Options Held
2.47M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...